Expression of the C-C chemokine MIP-3α/CCL20 in human epidermis with impaired permeability barrier function

Experimental Dermatology

Volumn 11, Issue 2, 2002, Pages 135-142

  Schmuth, Matthias ^a   Neyer, S ^a   Rainer, C ^b   Grassegger, A ^a   Fritsch, P ^a   Romani, N ^a   Heufler, C ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Barrier function; Dendritic cells; Stratum corneum; Transepidermal water loss

Indexed keywords

CHEMOKINE; INTERLEUKIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; BETA CHEMOKINE; CCL20 PROTEIN, HUMAN; CCR6 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN;

ARTICLE; ATOPIC DERMATITIS; CELL CULTURE; CELL INVASION; CELL MATURATION; CELL MIGRATION; CONTACT DERMATITIS; CONTROLLED STUDY; DENDRITIC CELL; EPIDERMIS; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSURVEILLANCE; KERATINOCYTE; LYMPHOID TISSUE; MONOCYTE; MYCOSIS FUNGOIDES; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PSORIASIS; QUANTITATIVE ANALYSIS; SCLERODERMA; SKIN; SKIN BIOPSY; SKIN PERMEABILITY; STEM CELL; T LYMPHOCYTE ACTIVATION; TOXIC EPIDERMAL NECROLYSIS; DERMIS; GENETICS; METABOLISM; PERMEABILITY; SKIN DISEASE; UPREGULATION;

CELLS, CULTURED; CHEMOKINES, CC; DERMIS; EPIDERMIS; HUMANS; MACROPHAGE INFLAMMATORY PROTEINS; PERMEABILITY; RECEPTORS, CHEMOKINE; RNA, MESSENGER; SKIN; SKIN DISEASES; UP-REGULATION;

EID: 0036547277     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2002.110205.x     Document Type: Article

References (58)

1. Elias P M. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol 1983: 80 (Suppl.): 44-49.
2. Rees J. Understanding barrier function of the skin. Lancet 1999: 354: 1491-1492.
3. Proksch E, Feingold K R, Man M Q, Elias PM. Barrier function regulates epidermal DNA synthesis. J Clin Invest 1991: 87: 1668-1673.
4. Harris I R, Farrell A M, Grunfeld C, Holleran W M, Elias P M, Feingold K R. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. J Invest Dermatol 1997: 109: 783-787.
5. Lee S H, Elias P M, Proksch E, Menon G K, Mao-Quiang M, Feingold K R. Calcium and potassium are important regulators of barrier homeostasis in murine epidermis. J Clin Invest 1992: 89: 530-538.
6. Wood LC, Jackson S M, Elias P M, Grunfeld C, Feingold K R. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992: 90: 482-487.
7. Nickoloff B J, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 1994: 30: 535-546.
8. Lessard R J, Wolff K, Winkelmann R K. Induced shedding of the epidermal Langerhans's cells. Nature 1966: 212: 628-629.
9. Lessard R J, Wolff K, Winkelmann R K. The disappearance and regeneration of Langerhans cells following epidermal injury. J Invest Dermatol 1968: 50: 171-179.
10. Streilein J W, Lonsberry L W, Bergstresser P R. Depletion of epidermal Langerhans cells and Ia immunogenicity from tape-stripped mouse skin. J Exp Med 1982: 155: 863-871.
11. Proksch E, Brasch J, Sterry W. Integrity of the permeability barrier regulates epidermal Langerhans cell density. Br J Dermatol 1996: 134: 630-638.
12. Nishijima T, Tokura Y, Imokawa G, Seo N, Furukawa F, Takigawa M. Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption. J Invest Dermatol 1997: 109: 175-182.
13. Katoh N, Hirano S, Kishimoto S, Yasuno H. Acute cutaneous, barrier perturbation induces maturation of Langerhans' cells in hairless mice. Acta Derm Venereol 1997: 77: 365-369.
14. Udey M C, Peck R D, Pentland A P, Schreiner G F, Lefkowith J B. Antigen-presenting cells in essential fatty acid-deficient murine epidermis: Keratinocytes bearing class II (Ia) antigens may potentiate the accessory cell function of Langerhans cells. J Invest Dermatol 1991: 96: 950-958.
15. Proksch E, Brasch J. Influence of epidermal permeability barrier disruption and Langerhans' cell density on allergic contact dermatitis. Acta Derm Venereol 1997: 77: 102-104.
16. Kondo H, Ichikawa Y, Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 1998: 28: 769-779.
17. Sallusto F et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 1998: 28: 2760-2769.
18. Dieu M C et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998: 188: 373-386.
19. Sozzani S et al. Differential regulation of chemokine receptors during dendritic cell maturation: A model for their trafficking properties. J Immunol 1998: 161: 1083-1086.
20. Tanaka Y et al. Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur J Immunol 1999: 29: 633-642.
21. Iwasaki A, Kelsall B L. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med 2000: 191: 1381-1394.
22. Heufler C et al. Cytokine gene expression in murine epidermal cell suspensions: Interleukin 1 beta and macrophage inflammatory protein 1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture. J Exp Med 1992: 176: 1221-1226.
23. Lukas M et al. Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J Invest Dermatol 1996: 106: 1293-1299.
24. Weinlich G et al. Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cells. J Invest Dermatol 1998: 110: 441-448.
25. Rossi D L, Vicari A P, Franz-Bacon K, McClanahan T K, Zlotnik A. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Immunol 1997: 158: 1033-1036.
26. Hieshima K et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem 1997: 272: 5846-5853.
27. Hromas R et al. Cloning and characterization of exodus, a novel beta-chemokine. Blood 1997: 89: 3315-3322.
28. Nelson R T et al. Genomic organization of the cc chemokine mip-3alpha/ccl20/larc/exodus/scya20, showing gene structure, splice variants, and chromosome localization. Genomics 2001: 73: 28-37.
29. Charbonnier A S, Kohrgruber N, Kriehuber E, Stingl G, Rot A, Maurer D. Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal Langerhans cells. J Exp Med 1999: 190: 1755-1768.
30. Bell D et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999: 190: 1417-1426.
31. Kleeff J et al. Detection and localization of MIP-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer 1999: 81: 650-657.
32. Fushimi T, Kojima A, Moore M A, Crystal R G. Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth. J Clin Invest 2000: 105: 1383-1393.
33. Campbell J J, Hedrick J, Zlotnik A, Siani M A, Thompson D A, Butcher E C. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998: 279: 381-384.
34. Liao F, Rabin R L, Smith C S, Sharma G, Nutman T B, Farber J M. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 1999: 162: 186-194.
35. Krzysiek R et al. Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells. Blood 2000: 96: 2338-2345.
36. Niederwieser D et al. IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. J Immunol 1988: 140: 2556-2564.
37. Romani N et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Meth 1996: 196: 137-151.
38. Elias P M, Wood L C, Feingold K R. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Derm 1999: 10: 119-126.
39. Grubauer G, Elias P M, Feingold K R. Transepidermal water loss: The signal for recovery of barrier structure and function. J Lipid Res 1989: 30: 323-333.
40. Kreder D et al. Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J 1999: 18: 2472-2479.
41. Segre J A, Bauer C, Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 1999: 22: 356-360.
42. Jensen J M, Schutze S, Forl M, Kronke M, Proksch E. Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 1999: 104: 1761-1770.
43. McLellan AD, Brocker E B, Kampgen E. Dendritic cell activation by danger and antigen-specific T-cell signalling. Exp Dermatol 2000: 9: 313-322.
44. Wood L C, Elias P M, Sequeira-Martin S M, Grunfeld C, Feingold K R. Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. J Invest Dermatol 1994: 103: 834-838.
45. Bieber T, Ring J, Braun-Falco O. Comparison of different methods for enumeration of Langerhans cells in vertical cryosections of human skin. Br J Dermatol 1988: 118: 385-392.
46. Bauer J, Bahmer F A, Worl J, Neuhuber W, Schuler G, Fartasch M. A strikingly constant ratio exists between Langerhans cells and other epidermal cells in human skin. A stereologic study using the optical disector method and the confocal laser scanning microscope. J Invest Dermatol 2001: 116: 313-318.
47. Holzmann S, Koch F, Stoitzner P et al. Tape stripping leads to emigration of Langerhans cells from the epidermis, their entry into afferent lymphatics in vivo, and allows immigration of progenitors. J Invest Dermatol 2000: 114: 282.
48. Bos J D, Van Garderen I D, Krieg S R, Poulter L W. Different in situ distribution patterns of dendritic cells having Langerhans (T6+) and interdigitating (RFD1+) cell immunophenotype in psoriasis, atopic dermatitis, and other inflammatory dermatoses. J Invest Dermatol 1986: 87: 358-361.
49. Wollenberg A, Wen S, Bieber T. Langerhans cell phenotyping: A new tool for differential diagnosis of inflammatory skin diseases. Lancet 1995: 346: 1626-1627.
50. Morhenn V B. Langerhans cells may trigger the psoriatic disease process via production of nitric oxide. Immunol Today 1997: 18: 433-436.
51. Watanabe M, Tagami H, Horii I, Takahashi M, Kligman A M. Functional analyses of the superficial stratum corneum in atopic xerosis. Arch Dermatol 1991: 127: 1689-1692.
52. Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol 1994: 130: 452-456.
53. Heng MC, Kloss SG, Kuehn C S, Chase D G. The sequence of events in psoriatic plaque formation after tape-stripping. Br J Dermatol 1985; 112: 517-532.
54. Homey B et al. Up-regulation of macrophage inflammatory protein-3alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 2000: 164: 6621-6632.
55. Dieu-Nosjean M C et al. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 2000: 192: 705-718.
56. Nakayama T et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 2001: 13: 95-103.
57. Yang D et al. Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999: 286: 525-528.
58. Izadpanah A, Dwinell M B, Eckmann L, Varki N M, Kagnoff M F. Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: Mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol 2001: 280: G710-G719.